Novartis
NVS
NVS
926 hedge funds and large institutions have $20B invested in Novartis in 2015 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 335 increasing their positions, 330 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $21.4B → $20B (-$1.38B)
29% less call options, than puts
Call options by funds: $35.2M | Put options by funds: $49.4M
29% less funds holding in top 10
Funds holding in top 10: 59 → 42 (-17)
Holders
926
Holding in Top 10
42
Calls
$35.2M
Puts
$49.4M
Top Buyers
| 1 | +$237M | |
| 2 | +$121M | |
| 3 | +$66.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$64.9M |
| 5 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$62.6M |
Top Sellers
| 1 | -$72.9M | |
| 2 | -$53M | |
| 3 | -$51.3M | |
| 4 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$46.7M |
| 5 |
Parnassus Investments
San Francisco,
California
|
-$44M |